相关实验视频
Updated: Jan 15, 2026

07:14
Acupuncture in a Rat Model of Asthma
Published on: August 25, 2020
6.5K
Platycodon grandiflorum提取物减轻了喘发育期间的炎症 在活体和体外
Jie Liu1, Wei Li1, Jingchao Yu1
1Department of Head and Neck Thyroid Surgery, Cangzhou Hospital of Integrated TCM-WM, Hebei.Cangzhou City, Hebei 061000, China.
Analytical cellular pathology (Amsterdam)
|October 15, 2025
概括
普拉蒂科登格兰迪佛勒姆提取物 (PGE) 通过抑制炎症反应,有效地减少了大鼠的喘症状. 这种自然治疗可以调节类似收费的受体4/核因子kappa B (TLR4/NF-κB) 途径,为喘提供一种潜在的治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘是一种严重的全球呼吸道疾病,每天造成1000多人死亡.
- 喘的患病率和严重程度在全球范围内不断增加.
- 研究用于喘治疗的天然化合物至关重要.
研究的目的:
- 为了评估Platycodon grandiflorum提取物 (PGE) 对喘的治疗效果.
- 评估PGE在体内 (在老鼠) 和体外 (在细胞培养中) 的疗效.
主要方法:
- 三十只斯普拉格-道利大鼠被分为控制,喘和不同PGE剂量组.
- 组织学染色,流细胞测量和西部涂抹用于分析肺组织和炎症标志物.
- 用脂聚糖 (LPS) 刺激的老鼠气管上皮质 (RTE) 细胞用于体外验证.
主要成果:
- 在喘老鼠中,PGE治疗改善了肺组织病理,在高剂量组有显著影响.
- PGE减少了炎症细胞的透和TNF-α,IL-1β和IL-6的水平.
- PGE降低了TLR4和p-P65 (NF-κB通路) 的表达,并在LPS刺激的RTE细胞中降低了亡.
结论:
- 在喘模型中,PGE显示出显著的抗炎作用.
- 治疗机制涉及TLR4/NF-κB信号通路的调节.
- PGE显示出作为治疗喘的天然治疗剂的潜力.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Antiasthma Drugs: Methylxanthines
1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K

